Zhenwei Yu

917 total citations
60 papers, 671 citations indexed

About

Zhenwei Yu is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Zhenwei Yu has authored 60 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 15 papers in Molecular Medicine and 14 papers in Epidemiology. Recurrent topics in Zhenwei Yu's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Antibiotic Resistance in Bacteria (15 papers) and Antibiotic Use and Resistance (7 papers). Zhenwei Yu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Antibiotic Resistance in Bacteria (15 papers) and Antibiotic Use and Resistance (7 papers). Zhenwei Yu collaborates with scholars based in China, United States and Australia. Zhenwei Yu's co-authors include Lingyan Yu, Xiaoyi Sun, Wenquan Liang, Jinliang Chen, Saiping Jiang, Ke Ma, Hongyan Lv, Yuanyuan Lv, Jianqing Gao and Jianying Zhang and has published in prestigious journals such as PLoS ONE, Biomaterials and Scientific Reports.

In The Last Decade

Zhenwei Yu

48 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenwei Yu China 14 186 137 124 104 101 60 671
Allan J. Coukell United States 15 87 0.5× 92 0.7× 172 1.4× 88 0.8× 23 0.2× 23 1.1k
B Rouveix France 18 130 0.7× 103 0.8× 159 1.3× 171 1.6× 92 0.9× 62 923
Maria del Carmen Dios-Viéitez Spain 16 143 0.8× 28 0.2× 162 1.3× 59 0.6× 135 1.3× 24 643
Carlo Della Pepa Italy 11 313 1.7× 25 0.2× 138 1.1× 33 0.3× 130 1.3× 16 812
Ramin Pouriran Iran 20 70 0.4× 68 0.5× 257 2.1× 145 1.4× 24 0.2× 55 1.1k
Aynur Eren Topkaya Türkiye 7 34 0.2× 113 0.8× 117 0.9× 60 0.6× 37 0.4× 34 613
Chié Nakamura Japan 11 42 0.2× 47 0.3× 94 0.8× 175 1.7× 244 2.4× 38 632
Mihaela Ionescu Romania 15 41 0.2× 37 0.3× 156 1.3× 71 0.7× 43 0.4× 88 702
Abdullah A. Alshehri Saudi Arabia 16 38 0.2× 83 0.6× 259 2.1× 62 0.6× 74 0.7× 44 751
Matthew P. Rowan United States 16 61 0.3× 45 0.3× 260 2.1× 420 4.0× 24 0.2× 22 1.2k

Countries citing papers authored by Zhenwei Yu

Since Specialization
Citations

This map shows the geographic impact of Zhenwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenwei Yu more than expected).

Fields of papers citing papers by Zhenwei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenwei Yu. The network helps show where Zhenwei Yu may publish in the future.

Co-authorship network of co-authors of Zhenwei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenwei Yu. A scholar is included among the top collaborators of Zhenwei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenwei Yu. Zhenwei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Jin Woo, et al.. (2025). Prevalence of on time administration of carbapenem and its impact on PK/PD target attainment in hospitalized patients: a multicenter retrospective study. Frontiers in Cellular and Infection Microbiology. 15. 1690269–1690269.
2.
3.
4.
5.
Su, Wei, et al.. (2024). Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Drug Design Development and Therapy. Volume 18. 4459–4469.
6.
Zhu, Jianping, et al.. (2024). Machine learning–based prediction model for hypofibrinogenemia after tigecycline therapy. BMC Medical Informatics and Decision Making. 24(1). 284–284.
7.
Su, Wei, et al.. (2024). Population pharmacokinetics and individualized dosing of tigecycline for critically ill patients: a prospective study with intensive sampling. Frontiers in Pharmacology. 15. 1342947–1342947. 3 indexed citations
8.
Yu, Zhenwei, Haitao Yu, Ling Zhou, et al.. (2023). Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis. International Journal of Antimicrobial Agents. 61(6). 106812–106812. 6 indexed citations
9.
Yu, Zhenwei, Haitao Yu, Ling Zhou, et al.. (2023). Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis. Frontiers in Pharmacology. 14. 1298397–1298397. 2 indexed citations
10.
Yu, Lingyan, et al.. (2023). Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy. Frontiers in Pharmacology. 14. 1209815–1209815. 1 indexed citations
11.
Yu, Zhenwei, et al.. (2022). Prevalence and risk factors of tigecycline-induced liver injury: A multicenter retrospective study. International Journal of Infectious Diseases. 120. 59–64. 13 indexed citations
12.
Yu, Lingyan, Zhiliang Wang, Zhenwei Yu, Jianhua Feng, & Haibin Dai. (2021). Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy. Annals of Clinical and Translational Neurology. 8(8). 1764–1767.
13.
Yu, Zhenwei, et al.. (2021). Trends in Outpatient Prescribing Patterns for Ocular Topical Anti-Infectives in Six Major Areas of China, 2013–2019. Antibiotics. 10(8). 916–916. 9 indexed citations
14.
Yu, Lingyan, et al.. (2021). Anti-seizure Medication Prescription in Adult Outpatients With Epilepsy in China, 2013–2018. Frontiers in Neurology. 12. 649589–649589. 16 indexed citations
15.
16.
Yu, Lingyan, et al.. (2020). Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017. PLoS ONE. 15(1). e0227595–e0227595. 21 indexed citations
17.
18.
Sun, Xiaoyi, et al.. (2016). Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery. PLoS ONE. 11(12). e0167961–e0167961. 67 indexed citations
19.
Ma, Ke, Gang Han, & Zhenwei Yu. (2015). Current status of parenteral nutrition and enteral nutrition application: an assessment of nutritional prescriptions from 59 hospitals in the People’s Republic of China. Therapeutics and Clinical Risk Management. 11. 201–201. 8 indexed citations
20.
Chen, Jinliang, Xiaoyi Sun, Zhenwei Yu, Jianqing Gao, & Wenquan Liang. (2011). Influence of lipid components on gene delivery by polycation liposomes: Transfection efficiency, intracellular kinetics and in vivo tumor inhibition. International Journal of Pharmaceutics. 422(1-2). 510–515. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan J. Coukell Breakdown of academic impact, for papers by B Rouveix Breakdown of academic impact, for papers by Maria del Carmen Dios-Viéitez Breakdown of academic impact, for papers by Carlo Della Pepa Breakdown of academic impact, for papers by Ramin Pouriran Breakdown of academic impact, for papers by Aynur Eren Topkaya Breakdown of academic impact, for papers by Chié Nakamura Breakdown of academic impact, for papers by Mihaela Ionescu Breakdown of academic impact, for papers by Abdullah A. Alshehri Breakdown of academic impact, for papers by Matthew P. Rowan
Rankless by CCL
2026